- Home
- Pharmaceuticals
- 040-000-403 4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride
040-000-403 4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride
Category | Pharmaceutical raw materials |
Synonym | 4-(4-Methylpiperazinomethyl)benzoic acid, dihydrochloride |
CAS No. | 106261-49-8 |
Chemical Formula | C13H20Cl2N2O2 |
Appearance | White to off-white crystalline powder |
Package | Customized Package. |
Packaging | DRUM, Plastic Container |
Grade | Cosmetic grade |
Assay | ≥98% |
- Description
Description
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride Introduction:
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride is an intermediate of the anti-tumor drug imatinib. Imatinib is an oral drug used to treat the blast phase, accelerated phase, and chronic phase after failure of interferon treatment in adult patients with Philadelphia chromosome (Ber-Abl) positive chronic myelogenous leukemia (CML).
CML is a hematopoietic stem cell disease caused by abnormal DNA of stem cells in the bone marrow. Abnormal DNA will produce abnormal proteins, which interfere with the normal production of white blood cells in the bone marrow, and ultimately lead to a sharp increase in the number of white blood cells. Imatinib is also effective in the treatment of gastrointestinal stromal tumors, with an effective rate of about 50%.
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride Application:
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride is an intermediate of the anti-tumor drug imatinib.
4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride Specification
Color | White |
Quantity | Customized |
Formula Weight | 307.22 |
Physical Form | Crystal-Powder at 20°C |
Percent Purity | ≥98.0% (HPLC) |
Chemical Name or Material | 4-[(4-Methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride |
Related products: Wogonin, Evodiamine, Dasatinib Monohydrate